Sumitomo Chemical Co. Ltd. (TYO:4005) is looking to establish a new plant for the mass production of single-guide RNA, a…...

Japan's leading chemical industry newspaper
Filed Under: Pharma Tagged With: Crispr-Cas9, genome editing, medical, new facilities, nucleic acid drugs, production, Sumitomo Chemical
Sumitomo Chemical Co. Ltd. (TYO:4005) is looking to establish a new plant for the mass production of single-guide RNA, a…...